June 2015 tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2014/15 Invitation to Tender, dated 6 November 2014.
Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms and Pharmacodes
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website.
Where a product does not have a current Pharmacode, suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand before the 12th of the month prior to the date of listing. PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.
2014/15 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2018
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
1. Tenders awarded to pharmaceuticals where no other brand is listed.
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current subsidy (and price) | New subsidy (and price) | Sole supply brand (Supplier) |
Date of subsidy change | Sole Subsidised Supply date |
|---|---|---|---|---|---|---|
| Azithromycin | Oral liq 40 mg per ml; 15 ml, bottle |
$6.60 | $12.50 | Zithromax (Pfizer) |
1 August 2015 | 1 November 2015 |
| Bezafibrate | Tab 200 mg; 90 tablet, blister pack |
$9.70 | $9.05 | Bezalip (Actavis) |
1 August 2015 | 1 November 2015 |
| Bezafibrate | Tab long-acting 400 mg; 30 tablet, blister pack |
$5.70 | $6.78 | Bezalip Retard (Actavis) |
1 August 2015 | 1 November 2015 |
| Bisacodyl | Tab 5 mg; 200 tablet, bottle pack |
$4.99 | $5.99 | Lax-Tab (AFT) |
1 August 2015 | 1 November 2015 |
| Calamine | Crm, aqueous, BP; 100 g, tube |
$1.77 | $1.49 | Pharmacy Health (API) |
1 October 2015 | 1 January 2016 |
| Calamine | Lotn, BP; 2,000 ml, bottle |
$13.45 | $12.94 | PSM (API) |
1 October 2015 | 1 January 2016 |
| Dexamfetamine sulfate | Tab 5 mg; 100 tablet, bottle pack |
$16.50 | $17.00 | PSM (API) |
1 October 2015 | 1 January 2016 |
| Folic acid | Tab 0.8 mg; 1,000 tablet, bottle pack |
$19.80 | $20.60 | Apo-Folic Acid (Apotex) |
1 August 2015 | 1 November 2015 |
| Folic acid | Tab 5 mg; 500 tablet, bottle pack |
$10.21 | $10.92 | Apo-Folic Acid (Apotex) |
1 August 2015 | 1 November 2015 |
| Hydrocortisone acetate | Rectal foam 10%, CFC-free (14 applications); 21.1 g OP, aerosol |
$25.30 | $26.55 | Colifoam (Radiant) |
1 August 2015 | 1 November 2015 |
| Hydrogen peroxide | Soln 3% (10 vol); 100 ml, bottle |
$1.28 | $1.40 | Pharmacy Health (API) |
1 September 2015 | 1 December 2015 |
| Megestrol acetate | Tab 160 mg; 30 tablet, bottle pack |
$51.55 | $54.30 | Apo-Megestrol (Apotex) |
1 August 2015 | 1 November 2015 |
| Methylprednisolone | Tab 4 mg; 100 tablet, bottle pack |
$60.00 | $80.00 | Medrol (Pfizer) |
1 August 2015 | 1 November 2015 |
| Methylprednisolone | Tab 100 mg; 20 tablet, bottle pack |
$166.52 | $180.00 | Medrol (Pfizer) |
1 August 2015 | 1 November 2015 |
| Methylprednisolone acetate | Inj 40 mg per ml, 1 ml vial; 5 vials |
$33.50 | $40.00 | Depo-Medrol (Pfizer) |
1 August 2015 | 1 November 2015 |
| Methylprednisolone acetate with lidocaine [lignocaine] | Inj 40 mg per ml with lidocaine [lignocaine] 1 ml vial; 1 vial |
$7.50 | $9.25 | Depo-Medrol with Lidocaine (Pfizer) |
1 August 2015 | 1 November 2015 |
| Methylprednisolone (as sodium succinate) | Inj 40 mg vial; 1 vial |
$7.50 | $10.50 | Solu-Medrol (Pfizer) |
1 August 2015 | 1 November 2015 |
| Methylprednisolone (as sodium succinate) | Inj 125 mg vial; 1 vial |
$18.50 | $22.25 | Solu-Medrol (Pfizer) |
1 August 2015 | 1 November 2015 |
| Methylprednisolone (as sodium succinate) | Inj 500 mg vial; 1 vial |
$18.00 | $9.00 | Solu-Medrol (Pfizer) |
1 August 2015 | 1 November 2015 |
| Methylprednisolone (as sodium succinate) | Inj 1 g vial; 1 vial |
$37.50 | $16.00 | Solu-Medrol (Pfizer) |
1 August 2015 | 1 November 2015 |
| Moclobemide | Tab 150 mg; 500 tablet, blister pack |
$81.83 | $85.10 | Apo-Moclobemide (Apotex) |
1 August 2015 | 1 November 2015 |
| Moclobemide | Tab 300 mg; 100 tablet, blister pack |
$29.51 | $30.70 | Apo-Moclobemide (Apotex) |
1 August 2015 | 1 November 2015 |
| Morphine hydrochloride | Oral liq 1 mg per ml; 200 ml, bottle |
$8.84 | $8.84 | RA-Morph (Pfizer) |
1 August 2015 | 1 November 2015 |
| Morphine hydrochloride | Oral liq 2 mg per ml; 200 ml, bottle |
$11.62 | $14.00 | RA-Morph (Pfizer) |
1 August 2015 | 1 November 2015 |
| Morphine hydrochloride | Oral liq 5 mg per ml; 200 ml, bottle |
$14.65 | $18.00 | RA-Morph (Pfizer) |
1 August 2015 | 1 November 2015 |
| Morphine hydrochloride | Oral liq 10 mg per ml; 200 ml, bottle |
$21.55 | $26.00 | RA-Morph (Pfizer) |
1 August 2015 | 1 November 2015 |
| Nadolol | Tab 40 mg; 100 tablet, bottle pack |
$15.57 | $16.05 | Apo-Nadolol (Apotex) |
1 August 2015 | 1 November 2015 |
| Nadolol | Tab 80 mg; 100 tablet, bottle pack |
$23.74 | $24.70 | Apo-Nadolol (Apotex) |
1 August 2015 | 1 November 2015 |
| Norethisterone | Tab 350 mcg; 84 tablet, blister pack |
$6.00 | $6.25 | Noriday 28 (Pfizer) |
1 August 2015 | 1 November 2015 |
| Oxycodone hydrochloride | Cap immediate-release 5 mg; 20 capsule, blister pack |
$2.83 | $1.98 | OxyNorm (MundiPharma) | 1 August 2015 | 1 November 2015 |
| Oxycodone hydrochloride | Cap immediate-release 10 mg; 20 capsule, blister pack |
$5.58 | $3.91 | OxyNorm (MundiPharma) | 1 August 2015 | 1 November 2015 |
| Oxycodone hydrochloride | Cap immediate-release 20 mg; 20 capsule, blister pack |
$9.77 | $6.84 | OxyNorm (MundiPharma) | 1 August 2015 | 1 November 2015 |
| Pethidine hydrochloride | Tab 50 mg; 10 tablet, bottle pack |
$3.95 | $4.46 | PSM (API) |
1 September 2015 | 1 December 2015 |
| Pethidine hydrochloride | Tab 100 mg; 10 tablet, bottle pack |
$5.80 | $6.25 | PSM (API) |
1 September 2015 | 1 December 2015 |
| Phenobarbitone | Tab 15 mg; 500 tablet, blister pack |
$28.00 | $30.00 | PSM (API) |
1 October 2015 | 1 January 2016 |
| Phenobarbitone | Tab 30 mg; 500 tablet, blister pack |
$29.00 | $31.00 | PSM (API) |
1 October 2015 | 1 January 2016 |
| Phenytoin sodium | Inj 50 mg per ml, 2 ml ampoule; 5 ampoules |
$88.63 | $88.63 | Hospira (Hospira) |
1 August 2015 | 1 November 2015 |
| Phenytoin sodium | Inj 50 mg per ml, 5 ml ampoule; 5 ampoules |
$133.92 | $133.92 | Hospira (Hospira) |
1 August 2015 | 1 November 2015 |
| Quinapril with hydrochlorothiazide | Tab 10 mg with hydrochlorothiazide 12.5 mg; 30 tablet, blister pack |
$3.37 | $3.65 | Accuretic 10 (Pfizer) |
1 August 2015 | 1 November 2015 |
| Quinapril with hydrochlorothiazide | Tab 20 mg with hydrochlorothiazide 12.5 mg; 30 tablet, blister pack |
$4.57 | $4.78 | Accuretic 20 (Pfizer) |
1 August 2015 | 1 November 2015 |
| Trimethoprim | Tab 300 mg; 50 tablet, bottle pack |
$10.67 | $15.00 | TMP (Mylan) |
1 August 2015 | 1 November 2015 |
2. Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current subsidy (and price) |
New subsidy (and price) | Sole supply brand (Supplier) |
Date of listing/subsidy change for tender winning brand |
Date of reference pricing of other listed brands |
Sole Subsidised Supply date (and delisting of other listed brands) |
Brand (Supplier) affected by reference pricing and delisting |
|---|---|---|---|---|---|---|---|---|
| Aqueous cream | Crm; 500 g, pot |
$1.96 | $1.99 | AFT SLS-free (AFT) | 1 November 2015 | n/a | 1 April 2016 | AFT (AFT) |
| Bisacodyl | Suppos 10 mg; 10 suppositories, foil pack |
$3.00 per 6 suppositories | $3.78 per 10 suppositories | Lax-Suppositories (AFT) | 1 November 2015 | 1 January 2016 | 1 April 2016 | Dulcolax (Boehringer Ingelheim) |
| Cetomacrogol | Crm BP; 500 g, pot |
$3.15 | $2.74 | healthE (Jaychem) | 1 September 2015 | 1 November 2015 | 1 February 2016 | PSM (API) |
| Etoposide 1 | Inj 20 mg per ml, 5 ml vial; 1 vial |
$25.00 per 1 vial; $612.20 per 10 vials | $7.90 per 1 vial | Rex Medical (Rex Medical) |
1 February 2016 | 1 April 2016 | 1 July 2016 | Hospira (Hospira); Vepesid (Bristol-Myers Squibb) |
| Letrozole | Tab 2.5 mg; 30 tablet, blister pack |
$4.85 | $2.95 | Letrole (Mylan) |
1 November 2015 | 1 January 2016 | 1 April 2016 | Letraccord (Actavis) |
| Valaciclovir 2 | Tab 500 mg; 30 tablet, blister pack |
$102.72 | $6.42 | Vaclovir (Mylan) |
1 January 2016 | 1 March 2016 | 1 June 2016 | Valtrex (GSK) |
|
||||||||
3. Tenders awarded to pharmaceuticals where no brand is listed.
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Pack Price | Sole supply brand (Supplier) |
Listing date | Sole Subsidised Supply Status date |
|---|---|---|---|---|---|
| Dimethicone | Crm 10% pump bottle; 500 ml OP; bottle |
$4.90 | healthE Dimethicone 10% (Jaychem) | 1 September 2015 | 1 December 2015 |
| Valaciclovir 1 | Tab 1,000 mg; 30 tablet, blister pack |
$12.75 | Vaclovir (Mylan) |
1 January 2016 | 1 June 2016 |
| 1. Current valaciclovir Special Authority restrictions will apply until 1 March 2016, after which, no restrictions will apply. | |||||
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
4. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current subsidy (and price) | New subsidy (and price) |
Hospital Supply Brand (Supplier) |
DV Limit |
Date of subsidy change | Hospital Supply Status date |
|---|---|---|---|---|---|---|---|
| Alprostadil hydrochoride | Inj 500 mcg per ml, 1 ml ampoule; 5 ampoules |
$1,417.50 | $1,650.00 | Prostin VR (Pfizer) | 1% | 1 August 2015 | 1 October 2015 |
| Atracurium besylate | Inj 10 mg per ml, 2.5 ml ampoule; 5 ampoules |
$6.13 | $10.00 | Tracrium (GSK) | 1% | 1 November 2015 | 1 January 2016 |
| Atracurium besylate | Inj 10 mg per ml, 5 ml ampoule; 5 ampoules |
$9.19 | $12.50 | Tracrium (GSK) | 1% | 1 November 2015 | 1 January 2016 |
| Azithromycin | Oral liq 40 mg per ml; 15 ml, bottle |
$6.60 | $12.50 | Zithromax (Pfizer) | 1% | 1 August 2015 | 1 October 2015 |
| Bezafibrate | Tab 200 mg; 90 Tablet, blister pack |
$9.70 | $9.05 | Bezalip (Actavis) | 1% | 1 August 2015 | 1 October 2015 |
| Bezafibrate | Tab long-acting 400 mg; 30 tablet, blister pack |
$5.70 | $6.78 | Bezalip Retard (Actavis) | 1% | 1 August 2015 | 1 October 2015 |
| Bisacodyl | Tab 5 mg; 200 tablet, bottle pack |
$4.99 | $5.99 | Lax-Tab (AFT) | 1% | 1 August 2015 | 1 October 2015 |
| Calamine | Crm, aqueous, BP; 100 g, tube |
$1.77 | $1.49 | Pharmacy Health (API) | 1% | 1 October 2015 | 1 December 2015 |
| Calamine | Lotn, BP; 2,000 ml, bottle |
$13.45 | $12.94 | PSM (API) | 1% | 1 October 2015 | 1 December 2015 |
| Cetomacrogol | Crm BP; 100 g, tube |
$1.65 | $1.47 | healthE (Jaychem) | 1% | 1 November 2015 | 1 January 2016 |
| Cyclophosphamide | Inj 1 g vial; 1 vial |
$35.03 | $35.03 | Endoxan (Baxter) | 1% | 1 August 2015 | 1 October 2015 |
| Cyclophosphamide | Inj 2 g vial; 1 vial |
$70.06 | $70.06 | Endoxan (Baxter) | 1% | 1 August 2015 | 1 October 2015 |
| Dexamfetamine sulfate | Tab 5 mg; 100 tablet, bottle pack |
$16.50 | $17.00 | PSM (API) | 1% | 1 October 2015 | 1 December 2015 |
| Hydrocortisone acetate | Rectal foam 10%, CFC-free (14 applications); 21.1 g, aerosol |
$25.30 | $26.55 | Colifoam (Radiant) | 1% | 1 August 2015 | 1 October 2015 |
| Hydrogen peroxide | Soln 3% (10 vol); 100 ml, bottle |
$1.28 | $1.40 | Pharmacy Health (API) | 1% | 1 September 2015 | 1 November 2015 |
| Megestrol acetate | Tab 160 mg; 30 tablet, bottle pack |
$51.55 | $54.30 | Apo-Megestrol (Apotex) | 1% | 1 August 2015 | 1 October 2015 |
| Methylprednisolone acetate | Inj 40 mg per ml, 1 ml vial; 5 vials |
$33.50 | $40.00 | Depo-Medrol (Pfizer) | 1% | 1 August 2015 | 1 October 2015 |
| Methylprednisolone acetate with lidocaine [lignocaine] | Inj 40 mg per ml with lidocaine [lignocaine] 1 ml vial; 1 vial |
$7.50 | $9.25 | Depo-Medrol with Lidocaine (Pfizer) | 1% | 1 August 2015 | 1 October 2015 |
| Methylprednisolone (as sodium succinate) | Inj 40 mg vial; 1 vial |
$7.50 | $10.50 | Solu-Medrol (Pfizer) | 1% | 1 August 2015 | 1 October 2015 |
| Methylprednisolone (as sodium succinate) | Inj 125 mg vial; 1 vial |
$18.50 | $22.25 | Solu-Medrol (Pfizer) | 1% | 1 August 2015 | 1 October 2015 |
| Methylprednisolone (as sodium succinate) | Inj 500 mg vial; 1 vial |
$18.00 | $9.00 | Solu-Medrol (Pfizer) | 1% | 1 August 2015 | 1 October 2015 |
| Methylprednisolone (as sodium succinate) | Inj 1 g vial; 1 vial |
$37.50 | $16.00 | Solu-Medrol (Pfizer) | 1% | 1 August 2015 | 1 October 2015 |
| Methylprednisolone (as sodium succinate) | Tab 4 mg; 100 tablet, bottle pack |
$60.00 | $80.00 | Medrol (Pfizer) | 1% | 1 August 2015 | 1 October 2015 |
| Methylprednisolone (as sodium succinate) | Tab 100 mg; 20 tablet, bottle pack |
$166.52 | $180.00 | Medrol (Pfizer) | 1% | 1 August 2015 | 1 October 2015 |
| Moclobemide | Tab 150 mg; 500 tablet, blister pack |
$81.83 | $85.10 | Apo-Moclobemide (Apotex) | 1% | 1 August 2015 | 1 October 2015 |
| Moclobemide | Tab 300 mg; 100 tablet, blister pack |
$29.51 | $30.70 | Apo-Moclobemide (Apotex) | 1% | 1 August 2015 | 1 October 2015 |
| Morphine hydrochloride | Oral liq 1 mg per ml; 200 ml, bottle |
$8.84 | $8.84 | RA-Morph (Pfizer) | 1% | 1 August 2015 | 1 October 2015 |
| Morphine hydrochloride | Oral liq 2 mg per ml; 200 ml, bottle |
$11.62 | $14.00 | RA-Morph (Pfizer) | 1% | 1 August 2015 | 1 October 2015 |
| Morphine hydrochloride | Oral liq 5 mg per ml; 200 ml, bottle |
$14.65 | $18.00 | RA-Morph (Pfizer) | 1% | 1 August 2015 | 1 October 2015 |
| Morphine hydrochloride | Oral liq 10 mg per ml; 200 ml, bottle |
$21.55 | $26.00 | RA-Morph (Pfizer) | 1% | 1 August 2015 | 1 October 2015 |
| Nadolol | Tab 40 mg; 100 tablet, bottle pack |
$15.57 | $16.05 | Apo-Nadolol (Apotex) | 1% | 1 August 2015 | 1 October 2015 |
| Nadolol | Tab 80 mg; 100 tablet, bottle pack |
$23.74 | $24.70 | Apo-Nadolol (Apotex) | 1% | 1 August 2015 | 1 October 2015 |
| Oxycodone hydrochloride | Cap immediate-release 5 mg; 20 capsules, blister pack |
$2.83 | $1.98 | OxyNorm (MundiPharma) | 1% | 1 August 2015 | 1 October 2015 |
| Oxycodone hydrochloride | Cap immediate-release 10 mg; 20 capsules, blister pack |
$5.58 | $3.91 | OxyNorm (MundiPharma) | 1% | 1 August 2015 | 1 October 2015 |
| Oxycodone hydrochloride | Cap immediate-release 20 mg; 20 capsules, blister pack |
$9.77 | $6.84 | OxyNorm (MundiPharma) | 1% | 1 August 2015 | 1 October 2015 |
| Pethidine hydrochloride | Tab 50 mg; 10 tablet, bottle pack |
$3.95 | $4.46 | PSM (API) | 1% | 1 September 2015 | 1 November 2015 |
| Pethidine hydrochloride | Tab 100 mg; 10 tablet, bottle pack |
$5.80 | $6.25 | PSM (API) | 1% | 1 September 2015 | 1 November 2015 |
| Phenobarbitone | Tab 15 mg; 500 Tablet, blister pack |
$28.00 | $30.00 | PSM (API) | 1% | 1 October 2015 | 1 December 2015 |
| Phenobarbitone | Tab 30 mg; 500 tablet, blister pack |
$29.00 | $31.00 | PSM (API) | 1% | 1 October 2015 | 1 December 2015 |
| Quinapril with Hydrochlorothiazide | Tab 10 mg with hydrochlorothiazide 12.5 mg; 30 tablet, blister pack | $3.37 | $3.65 | Accuretic 10 (Pfizer) | 1% | 1 August 2015 | 1 October 2015 |
| Quinapril with Hydrochlorothiazide | Tab 20 mg with hydrochlorothiazide 12.5 mg; 30 tablet, blister pack | $4.57 | $4.78 | Accuretic 20 (Pfizer) | 1% | 1 August 2015 | 1 October 2015 |
| Trimethoprim | Tab 300 mg; 50 tablet, bottle pack |
$10.67 | $15.00 | TMP (Mylan) | 1% | 1 August 2015 | 1 October 2015 |
5. Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current subsidy (and price) | New subsidy (and price) | Hospital Supply Brand (Supplier) | DV Limit | Listing date | Hospital Supply Status date |
Brand (Supplier) affected by delisting |
|---|---|---|---|---|---|---|---|---|
| Aqueous cream | Crm; 100 g, tube | $1.23 | $1.00 | Pharmacy Health SLS-free (API) | 1% | 1 November 2015 | 1 January 2016 | AFT (AFT) |
| Aqueous cream | Crm; 500 g, pot | $1.96 | $1.99 | AFT SLS-free (AFT) | 1% | 1 November 2015 | 1 January 2016 | AFT (AFT) |
| Bisacodyl | Suppos 10 mg; 10 suppositories, foil pack |
$3.00 per 6 suppositories | $3.78 per 10 suppositories | Lax-Suppositories (AFT) | 1% | 1 November 2015 | 1 January 2016 | Dulcolax (Boehringer Ingelheim) |
| Cetomacrogol | Crm BP; 500 g, pot | $3.15 | $2.74 | healthE (Jaychem) | 1 % | 1 September 2015 | 1 November 2015 | PSM (API) |
| Ciprofloxacin | Inj 2 mg per ml, 100 ml bag; 10 bags | $41.00 | $30.58 | Cipflox (Mylan) | 1% | 1 January 2016 | 1 March 2016 | Aspen Ciprofloxacin (Aspen) |
| Etoposide 1 | Inj 20 mg per ml, 5 ml vial; 1 vial | $25.00 | $7.90 | Rex Medical (Rex Medical) |
1% | 1 February 2016 | 1 April 2016 | Hospira (Hospira) |
| Letrozole | Tab 2.5 mg; 30 tablet, blister pack |
$4.85 | $2.95 | Letrole (Mylan) |
1% | 1 November 2015 | 1 January 2016 | Letraccord (Actavis) |
| Valaciclovir 2 | Tab 500 mg; 30 tablet, blister pack |
$102.72 | $6.42 | Vaclovir (Mylan) |
1% | 1 January 2016 | 1 March 2016 | Valtrex (GSK) |
|
||||||||
6. Tenders awarded to pharmaceuticals where no brand is listed.
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Pack Price | Hospital Supply Brand (Supplier) |
DV Limit |
Listing date | Hospital Supply Status date |
|---|---|---|---|---|---|---|
| Bleomycin sulphate 1 | Inj 15,000 iu (10 mg) vial; 1 vial | $150.48 | DBL Bleomycin Sulfate (Hospira) |
1% | 1 August 2015 | 1 October 2015 |
| Dimethicone | Crm 10% pump bottle; 500 ml, bottle |
$4.90 | healthE Dimethicone 10% (Jaychem) | 1% | 1 September 2015 | 1 November 2015 |
| Folic acid | Tab 0.8 mg; 1,000 tablet, bottle pack | $20.60 | Apo-Folic Acid (Apotex) |
1% | 1 August 2015 | 1 October 2015 |
| Folic acid | Tab 5 mg; 500 tablet, bottle pack | $10.92 | Apo-Folic Acid (Apotex) |
1% | 1 August 2015 | 1 October 2015 |
| Norethisterone | Tab 350 mcg; 84 tablet, blister pack |
$6.25 | Noriday 28 (Pfizer) |
1% | 1 August 2015 | 1 October 2015 |
| Phenytoin sodium | Inj 50 mg per ml, 2 ml ampoule; 5 ampoules |
$88.63 | Hospira (Hospira) |
1% | 1 August 2015 | 1 October 2015 |
| Phenytoin sodium | Inj 50 mg per ml, 5 ml; 5 ampoules |
$133.92 | Hospira (Hospira) |
1% | 1 August 2015 | 1 October 2015 |
| Potassium dihydrogen phosphate | Inj 1 mmol per ml, 10 ml ampoule; 10 ampoules | $151.80 | Hospira (Hospira) |
1% | 1 August 2015 | 1 October 2015 |
| Sodium dihydrogen phosphate | Inj 1 mmol per ml, 20 ml ampoule; 5 ampoules | $47.50 | Biomed (Biomed) |
1% | 1 August 2015 | 1 October 2015 |
| Valaciclovir 2 | Tab 1,000 mg; 30 tablet, blister pack |
$12.75 | Vaclovir (Mylan) |
1% | 1 January 2016 | 1 March 2016 |
|
||||||
Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status
PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2013/14 Invitation to Tender, dated 7 November 2013, and the 2014/15 Invitation to Tender, dated 6 November 2014:
2013/14 Invitation to Tender
| Chemical name | Line item |
|---|---|
| Lice treatment | Lotn |
| Lice treatment | Shampoo |
2014/15 Invitation to Tender
| Chemical name | Line Item |
|---|---|
| Bisacodyl | Suppos 5 mg |
| Calamine | Lotn, BP – 200 ml or less |
| Calcipotriol | Soln 50 mcg per ml (pack size 30 ml or less) |
| Calcipotriol | Soln 50 mcg per ml (pack size greater than 30 ml) |
| Condoms | Latex-free 54 mm or less (nominal width) |
| Etoposide | Inj 20 mg per ml, 50 ml |
| Etoposide phosphate | Inj 100 mg (of etoposide base) |
| Etoposide phosphate | Inj 1g (of etoposide base) |
| Famotidine | Tab 40 mg |
| Folic Acid | Inj 5 mg per ml, 10 ml |
| Fondaparinux sodium | Inj 7.5 mg syringe |
| Hydrogen peroxide | Crm 1% |
| Minocycline hydrochloride | Cap 100 mg |
| Minocycline hydrochloride | Tab 50 mg |
| Mupirocin | Oint 2% |
| Rocuronium bromide | Inj 10 mg per ml, 5 ml |
| Trimethoprim | Oral liq |
| Trimethoprim | Tab 100 mg |
| Urokinase | Inj 50,000 iu |
| Valaciclovir [current access] | Tab 250 mg |
| Valaciclovir [current access] | Tab 500 mg |
| Valaciclovir [current access] | Tab 1000 mg |
| Valaciclovir [no SA restrictions] | Tab 250 mg |
Tender declines - Products where no tender is to be awarded for Hospital Supply Status
PHARMAC has resolved not to award tenders for Hospital Supply Status for the following products listed in the 2014/15 Invitation to Tender, dated 6 November 2014:
2014/15 Invitation to Tender
| Chemical name | Line item |
|---|---|
| Oil in Water Emulsion | Crm |
For products included in the 2013/14 and 2014/15 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.
If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.